Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haiqing Xie
Observed name:
Xie, Haiqing
Institutions:
Second Affiliated Hospital of Nanjing Medical University,
Chenzhou First People's Hospital,
Nanjing Medical University
Observed institutions:
Guangzhou First People's Hospital,
Second Affiliated Hospital of Nanjing Medical University,
Chenzhou First People's Hospital,
Nanjing Medical University,
Guangzhou Medical University
ORCID:
0009-0001-0478-6448
Observed ORCID:
0009-0001-0478-6448
OpenAlex ID:
A5047972838
Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials
2024
·
Jian Pang
, Nianhua Ding
, et al.
·
Annals of Surgical Oncology
·
67
Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial
2024
·
Nianhua Ding
, Jian Pang
, et al.
·
Breast Cancer Research
·
15
PDF
Evaluating axillary lymph node metastasis risks in breast cancer patients via Semi-ALNP: a multicenter study
2025
·
Limeng Qu
, Jinfeng Zhu
, et al.
·
EClinicalMedicine
·
13
PDF
MLN2238 synergizes BH3 mimetic ABT-263 in castration-resistant prostate cancer cells by induction of NOXA
2014
·
Xinghua Wei
, Ping Zhou
, et al.
·
Tumor Biology
·
10
Plasma proteasomal chymotrypsin-like activity correlates with prostate cancer progression
2015
·
Xiangrong Deng
, Ping Zhou
, et al.
·
Tumor Biology
·
7
The Systemic Immune-Inflammation Index is a Predictor of Chemotherapy Sensitivity and Disease-Free Survival in Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
2024
·
Xuan Liu
, Guoqing Yan
, et al.
·
Clinical Breast Cancer
·
6
Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: a multicenter real-world study
2025
·
Jing Peng
, Qitong Chen
, et al.
·
Therapeutic Advances in Medical Oncology
·
2
The Role of Pyroptosis in Colorectal Cancer: From Mechanisms to Therapeutic Opportunities
2025
·
Haiqing Xie
, Xueting Deng
, et al.
·
Cancer Management and Research
·
1
PDF
Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: A multicenter real-world study.
2025
·
Wenjun Yi
, Jing Peng
, et al.
·
Journal of Clinical Oncology
PDF
ASO Author Reflections: Reflections on the Role of the Systemic Immune-Inflammation Index in Prognostic Assessment in HER2-Positive Metastatic Breast Cancer
2024
·
Jian Pang
, Nianhua Ding
, et al.
·
Annals of Surgical Oncology
Show more works
View as search
Works count:
13
Citation count:
121
H-index:
6
I10-index:
4
Year
Topic
Type